跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ERMYCIN 250 TABLET 250 MG - HSA Drug Approval Details
Approvals
/
HSA
/
ERMYCIN 250 TABLET 250 MG
Approved
THERAPEUTIC
ERMYCIN 250 TABLET 250 MG
REMEDICA LTD (BUILDING 1- GENERAL PRODUCTS) (CYPRUS)
🇸🇬 Health Sciences Authority
Approval Date
Nov 1, 1993
Approval ID
13f8030da22611be
Company
REMEDICA LTD (BUILDING 1- GENERAL PRODUCTS) (CYPRUS)
Type
Therapeutic
Approval Details
Approval Id
13f8030da22611be
Drug Name
ERMYCIN 250 TABLET 250 MG
Product Name
ERMYCIN 250 TABLET 250 MG
Approval Number
SIN07545P
Approval Date
1993-11-01
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Licence Holder
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
J01FA01
Atc Item Name
erythromycin
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Active Ingredients
ERYTHROMYCIN STEARATE EQV ERYTHROMYCIN
250 mg
ERYTHROMYCIN STEARATE EQV ERYTHROMYCIN
250 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 1, 1993
Approval ID
13f8030da22611be
Type
Therapeutic
Back to HSA Approvals